EFFECT OF FILGOTINIB ON PATIENT-REPORTED OUTCOMES IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM EQUATOR, A RANDOMIZED, PHASE 2 STUDY

Category Primary study
JournalANNALS OF THE RHEUMATIC DISEASES
Year 2019
This article has no abstract
Epistemonikos ID: 1337bca0fb689e7bc5773c148f7d1b83e7fcea96
First added on: Feb 15, 2022